Prenatal treatment of congenital adrenal hyperplasia: report of a new case
- PMID: 2406146
- DOI: 10.1007/BF02106280
Prenatal treatment of congenital adrenal hyperplasia: report of a new case
Abstract
A mother at risk for 21-hydroxylase deficiency was treated with oral dexamethasone (0.5 mg 12 hourly) from early pregnancy, in an attempt to prevent in utero virilization in case of a female fetus. Fetal karyotype was 46,XX, and because of a possible intra HLA recombination, treatment was continued to term. The newborn had a modest virilization and hormonal studies confirmed the diagnosis of congenital adrenal hyperplasia (CAH). This observation and review of the literature suggest that efficient prenatal treatment of CAH requires a higher and more frequent dosage of dexamethasone.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials